Noveltreat 0.25mg Injection may be prescribed for:

• Chronic weight management: It is used along with a reduced-calorie diet and increased physical activity to support weight loss and long-term weight management.

• Overweight with weight-related health conditions: It may be prescribed for adults who are overweight or have obesity with certain weight-related health conditions, as determined by the doctor. 

The 0.25mg strength is used as part of the dose-escalation schedule prescribed by the doctor. Do not increase the dose without medical advice.

Semaglutide works in a similar way to the natural hormone GLP-1. It acts on areas of the brain involved in appetite regulation, helping reduce hunger and food cravings while increasing feelings of fullness. This can reduce calorie intake and support weight management when combined with a reduced-calorie diet and increased physical activity. 

Semaglutide also slows stomach emptying, which can contribute to a longer-lasting feeling of fullness after meals.

Tell your doctor about all medicines, supplements, and herbal products you are taking before starting Noveltreat 0.25mg Injection.

• Insulin and certain diabetes medicines: Using Semaglutide with insulin or medicines such as sulfonylureas can increase the risk of low blood sugar.

• Medicines taken by mouth: Semaglutide can delay stomach emptying and may affect the absorption of some oral medicines.

• Other Semaglutide-containing medicines: Do not use Noveltreat with another Semaglutide-containing medicine unless your doctor specifically advises you to do so.

• Other GLP-1 receptor agonists: Do not combine Noveltreat with another GLP-1 receptor agonist unless prescribed by your doctor.

• Other weight-loss medicines: Tell your doctor if you are taking any other medicines intended for weight management.

• Store Noveltreat 0.25mg Injection in a refrigerator at 2°C to 8°C.

• Do not freeze.

• Protect the pen from light.

• Keep it out of reach of children.

• Follow the storage and handling instructions provided with the product packaging.

Noveltreat 0.25mg Injection is given as a subcutaneous injection once weekly, exactly as prescribed by your doctor. It can be injected into the abdomen, thigh, or upper arm and may be used at any time of the day, with or without food. Use it on the same day each week according to your prescribed schedule. 

Your doctor or healthcare professional should show you how to use the pre-filled pen before your first injection. Use a new needle for each injection and do not share the pen or needles with another person. Do not inject it into a vein or muscle.

Common side effects of Noveltreat 0.25mg Injection may include:

• Nausea

• Vomiting

• Diarrhoea

• Constipation

• Stomach or abdominal pain

• Reduced appetite

• Headache

• Tiredness

These effects may be more noticeable when treatment is started and generally improve as the body adjusts to treatment. 

Seek medical attention if you develop severe or persistent abdominal pain, especially if it spreads to the back, as this may be a sign of pancreatitis. Tell your doctor if you develop symptoms that may indicate gallbladder problems or a serious allergic reaction.

• Use Noveltreat 0.25mg Injection once weekly on the day prescribed by your doctor.

• Do not increase the dose or change the weekly schedule on your own.

• Follow the dose-escalation schedule recommended by your doctor.

• Eat smaller meals if you experience nausea or early fullness.

• Avoid greasy or high-fat meals if they worsen nausea.

• Drink enough fluids, particularly if vomiting or diarrhoea occurs.

• Follow the reduced-calorie diet and physical activity plan recommended by your healthcare professional.

• Tell your doctor if you have a history of pancreatitis, gallbladder problems, kidney problems, or severe gastrointestinal problems.

• Inform your healthcare team that you are using Semaglutide before surgery or procedures requiring anaesthesia or deep sedation.

• Use a new needle for each injection and never share your pen or needles.